Adherence biomarker measurements in older and younger HIV-infected adults receiving tenofovir-based therapy.

about

Development and Validation of an Assay to Analyze Atazanavir in Human Hair Via Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).

P2860

Q47724822-045B6387-95BA-4304-8981-A3F0B6A41364

P2860

Adherence biomarker measurements in older and younger HIV-infected adults receiving tenofovir-based therapy.

Item

http://www.wikidata.org/entity/Q45976122

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Adherence biomarker measuremen ...... iving tenofovir-based therapy.

@en

Adherence biomarker measuremen ...... iving tenofovir-based therapy.

@nl

type

Item

label

Adherence biomarker measuremen ...... iving tenofovir-based therapy.

@en

Adherence biomarker measuremen ...... iving tenofovir-based therapy.

@nl

prefLabel

Adherence biomarker measuremen ...... iving tenofovir-based therapy.

@en

Adherence biomarker measuremen ...... iving tenofovir-based therapy.

@nl

P1476

Adherence biomarker measuremen ...... iving tenofovir-based therapy.

@en

P2093

Howard Horng

http://www.w3.org/2001/XMLSchema#string

Jennifer J Kiser

http://www.w3.org/2001/XMLSchema#string

Jia-Hua Zheng

http://www.w3.org/2001/XMLSchema#string

Jose R Castillo-Mancilla

http://www.w3.org/2001/XMLSchema#string

Karen Kuncze

http://www.w3.org/2001/XMLSchema#string

Kristine Erlandson

http://www.w3.org/2001/XMLSchema#string

Lane R Bushman

http://www.w3.org/2001/XMLSchema#string

Mary Morrow

http://www.w3.org/2001/XMLSchema#string

Monica Gandhi

http://www.w3.org/2001/XMLSchema#string

Peter L Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

No adjustments are needed for multiple comparisons

Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)

Prediction of creatinine clearance from serum creatinine

Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures

Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy

Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.

Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots.

The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.

Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study.

P31

scholarly article

P356

10.1097/QAI.0000000000001596

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29189417

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5807216

http://www.w3.org/2001/XMLSchema#string

Adherence biomarker measurements in older and younger HIV-infected adults receiving tenofovir-based therapy.

about

P2860

P2860

Adherence biomarker measurements in older and younger HIV-infected adults receiving tenofovir-based therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698

P921

P932